© 2024 WEMU
Serving Ypsilanti, Ann Arbor and Washtenaw County, MI
Play Live Radio
Next Up:
0:00 0:00
Available On Air Stations

Dr. Judy Heidebrink

  • The U.S. Food and Drug Administration, this month, granted accelerated approval to an Alzheimer’s drug that might slow the acceleration of memory loss for early-stage Alzheimer’s patients. But neurologist Dr. Judy Heidebrink at Michigan Alzheimer’s Disease Center at University of Michigan Health is looking at this drug with caution. WEMU’s Cathy Shafran brings us an in-depth discussion with Dr. Heidebrink about local hopes for the drug Lecanemab.